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Summary
A genome scan of ∼12-cM initial resolution was done
on 50 of a set of 51 carefully ascertained unilineal
multiplex families segregating the bipolar affective
disorder phenotype. In addition to standard multi-
point linkage analysis methods, a simultaneous-search
algorithm was applied in an attempt to surmount the
problem of genetic heterogeneity. The results revealed
no linkage across the genome. The results exclude
monogenic models and make it unlikely that two
genes account for the disease in this sample. These
results support the conclusion that at least several
hundred kindreds will be required in order to establish
linkage of susceptibility loci to bipolar disorder in
heterogeneous populations.
Introduction
Bipolar (BP) disorder, also known as “manic-depressive
illness” (MIM 125480), is a common disease affecting
Received February 12, 1999; accepted for publication October 26,
1999; electronically published December 28, 1999.
Address for correspondence and reprints: Dr. J. Raymond DePaulo,
Department of Psychiatry, Johns Hopkins University School of Med-
icine, Meyer 3-181, 600 N. Wolfe Street, Baltimore, MD 21287-7381.
E-mail: jrd@welchlink.welch.jhu.edu
* Present affiliation: Lawrence Berkeley National Laboratory, Ber-
kely, CA.
† Present affiliation: Mayo Clinic, Rochester, MN.
‡ Present affiliation: Whitehead Institute for Biomedical Research,
Cambridge, MA.
§ Present affiliation: University of Chicago, Chicago.
k Present affiliation: University of Maryland School of Medicine,
Baltimore.
# Present affiliation: Genomica Corporation, Boulder, CO.
 2000 by The American Society of Human Genetics. All rights reserved.
0002-9297/2000/6601-0024$02.00
∼1% of the world’s population (Weissman et al. 1996).
Since the earliest descriptions of BP disorder, a striking
familial incidence has been noted (Kraepelin 1921). Fur-
ther twin, adoption, and family studies have supported
a genetic etiology, and, with the advent of modern ge-
netic maps, this disease has become an attractive target
for linkage analysis (see MacKinnon et al. 1997). Since
1968, 150 studies have attempted to identify the loci
responsible for BP disorder. Although 120 loci have been
implicated, few of the data in these reports could be
confidently distinguished from chance findings (Dupuis
et al. 1995; Kruglyak and Lander 1995).
One of the most widely studied regions is located on
chromosome 18p, where Berrettini et al. (1994) first re-
ported evidence for linkage to BP disorder. Several
groups, both ours (Stine et al. 1995; McMahon et al.
1997) and others (McInnes et al. 1996; No¨then et al.
1999), have reported evidence supporting linkage to
chromosome 18, including this region. Each of these
data sets provided statistical evidence reaching the sug-
gestive level but not the level recommended (see Lander
and Kruglyak 1995) as being statistically significant. A
metanalysis was performed on the three data sets noted
above and on two others (Knowles et al. 1998; Rice
1997). The genotypes and phenotypes of the 382 af-
fected sib pairs in the 185 kindreds analyzed (Lin and
Bale 1997) supported linkage, with statistical signifi-
cance ( ).8P = 2 # 10
Evidence for linkage to loci in 18q21-23 also has been
observed by several groups (Stine et al. 1995; McInnes
et al. 1996; McMahon et al. 1997; No¨then et al. 1999).
However, the number of loci, the location(s) of the loci,
and the role of a parent-of-origin effect (McMahon et
al. 1995) on the linkage evidence are not well defined.
Evidence for linkage to 21q (Straub et al. 1994), 4p
(Blackwood et al. 1996), and 12q (Barden and Moris-
sette 1999), implicated in single kindreds selected from
larger family sets, has also been supported by the results
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of some studies (Detera-Wadleigh et al. 1996; Smyth et
al. 1997; Gurling et al. 1998; Aita et al. 1999; Craddock
and Lendon 1999) but not by findings from the majority
of independent follow-up studies. The results of a large
number of studies of chromosomes 4, 12, 18, and 21
have recently been published (Curtis 1999; Detera-Wad-
leigh 1999; Kennedy et al. 1999; Van Broeckhoven and
Verheyen 1999).
Potential reasons for difficulty in linkage mapping of
BP disorder are not hard to find. Because the pathology
and pathophysiology of the disorder are unknown, the
diagnosis and consequent phenotypic classification of BP
disorder are made solely on the basis of clinical grounds.
The underlying genetic mechanisms are unknown: sev-
eral genes could act together in a given individual to
cause disease, or several genes, each of which causes the
disease in different families (genetic heterogeneity), could
be present in the population. In either circumstance, we
agree with others who suggest that, without evaluation
of several hundred or more kindreds with BP disorder,
genomewide linkage studies will usually fail to detect or
confirm linked loci. In addition, maps that are much
more informative than those typically in use and analytic
strategies that are explicitly designed to detect loci in
complex disorders (Risch and Merikangas 1996;
Visscher et al. 1998; Cox et al. 1999) might be required.
At the time when we began the ascertainment of fam-
ilies with multiple cases of BP disorder, we assumed that
genetic heterogeneity would constitute the main com-
plexity. This seemed surmountable with the use of link-
age methods just then being reduced to practice (Ott
1991), combined with a strategy that we called “simul-
taneous search” (Lander and Botstein 1986b). In prin-
ciple, with the use of data covering the entire genome,
simultaneous search would evaluate loci pairwise,
thereby minimizing the chance that data from a family
whose disease is caused by one locus would decrease the
significance of the data from families whose disease is
caused by another locus. The simultaneous-search al-
gorithm might therefore be expected to increase the
power of linkage analysis to resolve two or more loci
acting independently in a population. We believed that
this would be particularly advantageous in an instance
in which a small number of dominant loci were each
segregating in a different subset of our pedigrees.
Families were ascertained through a treated proband
with BP type 1 (BPI) who had two or more affected
siblings or at least one affected sibling and one affected
parent. In all families, one parent had to be unaf-
fected—that is, free of recurrent unipolar depression
(RUP) or BP affective disorder after being directly ex-
amined in the study. All available family members were
interviewed by fully trained psychiatrists using the
Schedule for Affective Disorders and Schizophrenia–
Lifetime Version (SADS-L) interview. Two noninterview-
ing psychiatrists made best-estimate diagnoses on the
basis of all available family-history medical record and
interview data and by use of Research Diagnostic Cri-
teria (Spitzer et al. 1978). They also assigned phenotypes
by means of a conservative method (i.e., both psychia-
trists had to agree that the case met criteria either for
one of the “affected” conditions or for one of the “un-
affected” diagnoses, or the case was called “phenotype
unknown”). Despite the observation (Simpson et al.
1992) that most ascertained families were bilineal (i.e.,
affected individuals were found among the first-degree
relatives of both parents), 51 apparently unilineal fam-
ilies were chosen for this study; one of the families was
dropped as a result of allele-segregation inconsistencies.
We estimated that we needed 50 families with three fully
informative meioses per family, on the basis of a sim-
ulation of a simultaneous-search method, given a perfect
20-cM marker map of the genome (Lander and Botstein
1986b). To bias the sample toward families with the
simplest modes of inheritance, we included only those
families that appeared to be unilineal. Indeed, we found
it extremely difficult to find sufficient numbers of fam-
ilies with three affected siblings (proband and two other
siblings) and one clearly unaffected parent (Simpson et
al. 1992), and therefore we included families with two
or more affected siblings and one affected parent as well
as one unaffected parent. When the ascertainment bias
was ignored, the segregation of the disease phenotype
in most of the 50 families resembled the expectation for
simple dominant inheritance of a highly predisposing
gene in each family (fig. 1).
The results of previous studies (McMahon et al. 1995)
in this sample demonstrated clinical evidence for a par-
ent-of-origin effect, with excess maternal transmission.
When this effect was included in an early linkage analysis
of chromosome 18 (Stine et al. 1995), the evidence for
linkage was increased in paternal transmission and in
paternal families (i.e., families that show predominant
transmission of the disease through the father). Several
studies show evidence of a parent-of-origin effect in fa-
milial BP disorder but raise questions about the nature
of the effect (Gershon et al. 1996) and about the best
way to include it in linkage analysis (McMahon et al.
1997; No¨then et al. 1999). In addition, at least a few
studies report no parent-of-origin effect (Kato et al.
1998). Although inclusion of this effect in this genome-
wide analysis would be reasonable, we chose not to do
so, since it was not part of our original hypothesis, since
it is not clear how to include it as a variable in the
analysis, and since its inclusion would increase the df of
the analysis.
Here we present the results of the experiment as orig-
inally planned: genomewide analysis, by means of both
standard analysis and the simultaneous-search strategy,
of 50 families with BP disorder (in this case, 50 of the
Figure 1 Pedigrees of the 50 families studied. Only the generations used for genotyping are shown, and unaffected individuals as well as
those with BPI, BPII, and RUP diagnoses are shown.
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58 families had been previously studied by McMahon
et al. 1997). The results are sufficient to exclude—in
most of the genome, including the loci previously im-
plicated in the studies cited above—a single gene ac-
counting for disease in half the families in this sample.
A similar genome scan of 96 kindreds has been published
(Edenberg et al. 1997; Rice et al. 1997; Detera-Wadleigh
et al. 1997; Stine et al. 1997), with similar results. We
conclude, in agreement with findings from the earlier
reports, that one gene or a combination of two genes
acting independently are unlikely to account for the ob-
served familial clustering of BP disorder generally.
Subjects and Methods
Family Ascertainment
Families were ascertained through a treated proband
with BPI who had either two or more affected siblings
or at least one affected sibling and one affected parent
(Simpson et al. 1992). In all families, one parent had to
be unaffected—that is, free of RUP or BP affective dis-
order after being directly examined in the study. All
available family members were interviewed by fully
trained psychiatrists using the SADS-L interview. Two
noninterviewing psychiatrists made best-estimate diag-
noses on the basis of all available family-history medical
record and interview data and by the use of Research
Diagnostic Criteria (Spitzer et al. 1978), with the ad-
ditional requirement that, for the diagnosis of BP type
2 (BPII), there be recurrent episodes of major depression.
Phenotypes were assigned by means of a conservative
method. Both psychiatrists had to agree that the case
met criteria for one of the “affected” diagnoses (BPI,
BPII, RUP, or schizoaffective manic-type [SAM]) or for
one of the “unaffected” diagnoses; otherwise, the case
was called “phenotype unknown.” Families in which
individuals with BPI, BPII, or RUP were found among
both the parents or among parental first-degree relatives
were excluded. Although 51 families were ascertained,
the collection analyzed comprises 50 families containing
470 individuals, among whom there were 108 BPI phe-
notypes, 75 BPII phenotypes, and 53 RUP phenotypes.
Figure 1 summarizes the family pedigrees.
Genotyping
All the genotypes reported here were determined by
the multiplex method, as described elsewhere (Clark and
Gschwend 1994). The first 28 families ascertained had
been analyzed by linkage analysis with simple-tandem-
repeat polymorphism (STRP) markers, as reported else-
where (Stine et al. 1995). Of an additional 23 families
that were later ascertained by the same methods, 22 were
genotyped again, with use of an improved set of markers.
On the basis of a preliminary analysis of the first
135,000 genotypes, 36 additional markers were added
to improve the information in regions (with multipoint
LOD score under the assumption of heterogeneity
[HLOD] 11.5). This threshold was chosen on the basis
of simulations that indicated that any locus capable of
generating an HLOD score 13 in this sample would yield
an HLOD 11.5 in our first pass of genotyping. A total
of three to six markers were added to these regions to
maximize the HLOD and/or information content. In all,
147,185 genotypes were determined, resulting in an av-
erage resolution of 12 cM; not all the same markers were
used throughout, but all of the Cooperative Human
Linkage Center–Set 6 markers were applied to all the
individuals. Marker data were analyzed with the use of
CRIMAP (Lander and Green 1987; Goldgar et al. 1989).
Simulation Methods
Simulations were conducted with the use of our ped-
igree structure and marker map, with a modification of
the GENEHUNTER algorithm. We ran our simulations
by placing the disease locus within a simulated map gen-
erated to match the markers used in this linkage analysis.
We then varied the heterogeneity parameter a, which
denotes the percentage of families in which the disease
allele is causative, during the simulation. This was fol-
lowed by GENEHUNTER analysis of the simulated data
(with a maximized in the analysis), to determine our
ability to detect genes of the percentage a used in the
simulation. Several independent simulations were run
for each simulated disease locus and simulated a.
Linkage Methods
Multipoint linkage analysis was done with the use of
both the GENEHUNTER software package (Kruglyak
et al. 1996) and an unpublished implementation (by L.
Kruglyak) of simultaneous search (Lander and Botstein
1986b). Linkage was evaluated under four models of
inheritance. The first was a dominant model that con-
sidered only individuals with BPI, BPII, or SAM as being
affected. These diagnoses were distinct from RUP, on the
basis of the presence of mania. The second model was
a dominant model, in which individuals with BPI, BPII,
SAM, or RUP were considered to be affected. The third
model was a recessive model, in which individuals with
BPI or BPII were considered to be affected. Similarly, the
fourth model was a recessive model, in which individuals
with BPI, BPII, or RUP were considered to be affected.
We did not have enough individuals with BPI to analyze
them separately. In each case, an age-dependent pene-
trance was assumed (.63–.85), as was an age-dependent
phenocopy rate (10%–19%). The disease-allele fre-
quency was set at .02 for the dominant models and at
.10 for the recessive models. Allele frequencies were cal-
culated from the data, and the recombination fractions
generated by CRIMAP were used as input map distances.
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Table 1
HLOD Scores for Simulations of Low Information Content
on Chromosome 1
HLOD Score at a = .50 HLOD Score at a = .33
At Peak At Disease Locus At Peak At Disease Locus
3.9 3.9 2.6 2.0
3.1 3.1 2.4 1.6
2.5 2.5 1.9 1.9
2.4 2.4 1.6 1.6
2.1 1.4 1.5 1.3
2.1 1.1 1.1 1.1
1.8 1.2 .8 8.4
1.7 1.7 .6 .0
1.3 1.3 .3 .1
1.0 1.0 .1 .1
1.0 .5 .1 .0
.1 .0 .0 .0
NOTE.—HLOD scores are given for each of 12 simulations
of a disease locus (a = .5 or .33) within a large gap between
markers. Information content was .3. Peak HLOD score is
given, as well as the HLOD score for the exact position of the
disease locus. These scores are sorted from highest to lowest.
GENEHUNTER calculated the multipoint HLOD and
estimated the fraction of the families segregating each
locus scored, as well as the information content at the
position of each marker and at the midpoint between
markers. The information content is a measure (range
.0–1.0) of the fraction of the total inheritance infor-
mation extracted by the available marker data. GENE-
HUNTER runs were made with a allowed to vary, to
maximize the HLOD score, and also with a fixed, to
estimate the power to exclude models in which one or
more loci could account for the disease in 50% and 33%
of the families, respectively. The HLOD scores and their
positions, as generated by GENEHUNTER, were used
as input for a simultaneous-search program written by
Leonid Kruglyak and Eric Lander, as described elsewhere
(Gschwend et al. 1996), with computer code optimized
by Mark Schroeder. The simultaneous-search program
evaluated linkage at all marker positions and at the mid-
point between markers, for all chromosomes and all ped-
igrees. The parameters a1 and a2 (in this case, the frac-
tion of families attributed to each potential locus) were
set to .44 for the simultaneous search. This corresponds
to the average a that yielded the highest HLOD scores
in our genome scan.
Results
Simulations
Using the actual family set and our actual markers,
we performed two sets of simulations designed to test
the power to detect loci for BP disorder in this sample.
To determine our ability to detect genes of low a in the
weakest region of our genome scan, we placed the dis-
ease locus in the middle of a 22-cM gap on chromosome
1 (information content .3) and then allowed the com-
puter to generate the genotypes at the surrounding mark-
ers, for several values of a. Similarly, we placed a sim-
ulated disease locus at a position of good information
content (.8) on chromosome 8, in an effort to determine
what LOD score would be expected, in our family set,
from a true linkage in a region of high information, such
as that which we obtained when adding additional
nearby markers.
Simulations placing the disease locus in the middle of
the gap on chromosome 1, with an a of 1.0 (i.e., no
heterogeneity), produced a LOD-score range of 9–10.
Thus, there is little question that, with this family and
marker set, we would have detected linkage if a single
gene anywhere in the genome were causing most of the
disease in this population. With a at .5, the peak-LOD-
score range was 0.1–3.9 (table 1). Of 12 simulations, 4
(33%) yielded peak LOD scores 11.5, which is the
threshold that we used for application of additional
markers in the neighborhood; this finding suggests that,
in a future scan, one might want to use a slightly lower
threshold. Only 1 (8%) of 12 simulations had a LOD
score that fell below the score of 0.4 that was actually
observed in this interval (fig. 2). To determine our ability
to detect a less-common locus, we simulated a disease
locus causing disease in only one-third (i.e., ) ofa = .33
the families. Seven (58%) of 12 simulations failed to
yield a LOD score 11.5, which is the threshold used for
secondary genotyping (table 1). Thus, where our infor-
mation is weakest, we would generally have detected a
locus accounting for disease in half the families, but we
would have succeeded only half the time if the locus
accounted for disease in only one-third of the families.
The simulations in the gap on chromosome 1 estimate
the likelihood that a true disease locus at a given a in
our weakest map position would be detected in the first
round of genotyping. Once a disease locus was detected
(i.e., provided a LOD score 11.5) in the first analysis,
we added additional markers. This provided an infor-
mation density similar to that in the region that we sim-
ulated on chromosome 8, where the disease locus was
placed in a region where the marker spacing is 4 cM.
In the case of no heterogeneity ( ), the LOD scoresa = 1
were 16–20. At , the LOD-score range was 3.4a = .5
–8.7 (table 2). This indicates that we would have ob-
served a significant LOD score (11 successes in 11 tries)
for any true locus that passed the original screening at
LOD 11.5. We then addressed the issue of detection of
a less common locus, by setting a at .33. Five (42%) of
12 runs gave us a LOD score 13.0, indicating that iden-
tification of a locus responsible for disease in one-third
of the pedigrees would have been difficult (table 2). The
power would have been lower in samples with higher
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Figure 2 Results from GENEHUNTER analysis. Each chromosome is separately plotted. The information content (scale in black on right-
side ordinate) at each marker and at the midpoint between markers is shown. Also shown are the HLOD scores (scale on the leftside ordinate)
for four models (see text), as well as for a = .5 (to estimate exclusion), again evaluated at markers and at the midpoint between markers.
heterogeneity. For example, in the linkage analysis of 58
families with BP (including the 50 families reported
here), the maximal HLODs obtained at loci in 18q21-
22 were associated with an a value of 25% (McMahon
et al 1997). Thus, the estimates for the likelihood of
detection and the power to exclude agree. They show
that this family set should have been sufficient for de-
tection of a gene that accounts for disease in 50% of
the families. We would very likely have missed a gene
responsible for disease in one-third of the families.
Linkage-Analysis Results
Several statistics were obtained from the linkage anal-
ysis, by use of GENEHUNTER (Kruglyak et al. 1996);
a summary of these statistics, over the entire genetic
length of the human genome, is given infigure 2. First,
the position of each marker is given, along with the
information content (see the Subjects and Methods sec-
tion). Second, the multipoint HLODs from GENE-
HUNTER are given. The results are shown for four mod-
els (for details, see the Subjects and Methods section):
a dominant model (with heterogeneity), in which only
individuals with BPI, BPII, or SAM were considered to
be affected; the same dominant model, in which only
individuals with BPI, BPII, SAM, or RUP were consid-
ered to be affected; a recessive model (with heteroge-
neity), in which only individuals with only BPI, BPII, or
SAM were considered to be affected; and the same re-
cessive model, in which only individuals with BPI, BPI
I, SAM, or RUP were considered to be affected. In these
small, nuclear families, the nonparametric-linkage sta-
tistics closely followed the HLOD statistics.
Examination offigure 2 shows three peaks with
HLOD scores 12. It should be recalled, in this context,
that the threshold for significance for genome scans is
3.3, although a consensus is emerging in favor of 3.6
(Kruglyak et al. 1996). The detailed data for the peaks
are given in table 3. The peaks may have arisen by chance
alone, as might be expected at this level of significance
(Dupuis et al. 1995; Lander and Kruglyak 1995). They
almost certainly reflect that our assessment of lineality,
albeit painstaking, was done on the basis of an insuf-
ficiently complex model of the genetics of BP disorder.
212 Am. J. Hum. Genet. 66:205–215, 2000
Table 2
LOD Scores for Simulations of High Information Content on
Chromosome 8
LOD Score at a = .50 LOD Score at a = .33
At Peak At Disease Locus At Peak At Disease Locus
8.7 7.6 7.1 6.0
6.6 6.5 5.7 5.3
6.3 5.4 5.6 5.5
5.3 5.3 5.4 4.8
5.3 4.5 5.2 5.2
4.3 4.3 3.9 3.3
4.3 4.3 3.4 2.8
4.2 3.7 2.3 2.3
4.1 4.1 1.0 .9
4.0 4.0 1.0 .8
3.4 3.4 .9 .7
.7 .6
NOTE.—HLOD scores are given for each simulation of a
disease locus (a = .50 or .33) within a 4-cM gap between
markers (information content .8). Both the peak LOD score
and the LOD score for the exact position of the disease locus
are given. These scores are sorted from highest to lowest.
Table 3
Multipoint HLOD Peaks 12.0
Flanking Marker(s)a
Positionb
(cM)
Information
Contentc HLOD ad Modele
D4S408, D4S426 258.01 .60 2.11 .41 Recessive
267.93 1.70 .46 Dominant w/o RUP
267.93 1.45 .34 Dominant
258.01 .91 .30 Recessive w/o RUP
D7S513 12.27 .69 2.17 .32 Recessive
1.77 .31 Recessive w/o RUP
.16 .11 Dominant
.05 .06 Dominant w/o RUP
D8S256, D8S272 177.88 .71 2.39 .42 Dominant w/o RUP
2.23 .32 Dominant
1.24 .29 Recessive w/o RUP
.08 .07 Recessive
a Located at or to either side of the peak HLOD.
b From the pter of the chromosome.
c Measure of how well the inheritance of marker loci is known in the families.
d Fraction of linked families that gives the maximum HLOD.
e Mode of disease inheritance under which the data were analyzed. “w/o RUP” indicates
that individuals with RUP were classified as being unaffected.
Simultaneous-Search Results
A major part of the motivation for this study was the
possibility that simultaneous search (Lander and Bot-
stein 1986a, 1986b) might, under restricted circum-
stances, allow resolution of two or more loci in the case
of heterogeneity, by separation of families in which dis-
ease is caused by one locus from those in which disease
is caused by the other locus. Simple calculations under
heterogeneity, such as those done forfigure 2, might
make use of less information than is inherent in the data.
We calculated the LOD scores over the genome by si-
multaneous search using two dominant loci or two re-
cessive loci. The highest points in the LOD-plot range
are 3.4–3.8 at the locus pair D8S272 and D9S264 and
at the locus pair D9S264 and D13S151. This is near the
level of significance for the second locus in a conditional
search and is therefore well below the threshold for an
unconditional search (Dupuis et al. 1995; Gschwend et
al. 1996).
Exclusion Analysis
Since we succeeded, with use of our markers, in ex-
traction of 50%–80% of the genetic information over
virtually all of the genome, we attempted to estimate
how strongly one might be able to exclude models in
which one or more loci could account for a substantial
fraction of the phenotype observed in the 50 families.
We did this in two ways. One of these ways, which is
a feature of GENEHUNTER (Kruglyak et al. 1996), is
to set the parameter a (i.e., the fraction of families at-
tributed to a potential locus) so that the resulting HLOD
score estimates the likelihood that a gene at a given locus
can account for that fraction of the families. The results
when a was set at .5 are plotted infigure 2. It is clear
that most of the genome (except for the X chromosome
and parts of chromosomes 9 and 13) is unlikely to con-
tain a gene that is causative for half of the families (i.e.,
HLOD is negative, generally 11). The conventional
criterion for exclusion (i.e., LOD 12) is met for ap-
proximately half the genome). We also did the calcu-
lations for other values of a, with the result that, with
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a at .3, the fraction of the genome that is excluded is
substantially less.
Discussion
Our results show that no single locus or pair of loci
can account for the disease in a substantial fraction of
the 50 families that we studied. The level of information
provided by the density and heterozygosity of the mark-
ers was sufficient to exclude from most of the ge-
nome—including both the loci implicated in previous
studies and 18q21 (where our data are consistent with
those of McMahon et al. [1997], when we analyze the
markers used in both studies)—such a causative gene
accounting for disease in half the families.
How then can we account for the generally negative
results of this analysis and for the strongly familial
occurrence of BP disorder? One possibility is extreme
heterogeneity—namely, that the disease is frequently
caused by a single dominant gene but that there are
many alternative such genes segregating in the pop-
ulation. The observation, by Blackwood et al. (1996),
of a strong indication of linkage (LOD score 4.1) in
only 1 of 12 comparable families, is consistent with
this view. This would not, however, account for the
frequent bilineality of BP disorder, as defined in our
ascertainment (Simpson et al. 1992).
An alternative genetic model, which may produce
pseudodominant segregation in some cases and bili-
neality in others, is the “complex inheritance” or as a
“quantitative-trait model,” in which a number of dif-
ferent, relatively common disease alleles, when
combined in a single individual, predispose to BP dis-
order. Such disease alleles could contribute relative risks
of 5 or much less than 2. Such a circumstance would
generally produce bilineality, could show a 1:1 ratio in
affected sibships, and might even occasionally result in
a rare family (Straub et al. 1994; Blackwood et al. 1996;
Barden and Morissette 1999; Craddock and Lendon
1999) in which a particular allele could be followed by
linkage methods, by use of a simple dominant model of
BP disorder. In general, however, both the number of
genes involved in individuals with a common condition
such as BP disorder and the consequent high frequency
of them all would defeat linkage analysis of the kind
that we have performed.
We conclude that any underlying genetic etiology of
BP disorder is too complex to be resolved in genome
scans with single-major-locus assumptions and in link-
age analyses involving fewer than many hundreds of
multiplex families. Since the data on the subset of 28
families reported by Stine et al. (1995) were found to
be useful to analysts and generated more than a dozen
published papers, with this publication we are making
all genetic data, including all 147,000 genotypes col-
lected, available to the scientific community. The data
can be found at the Dana Bipolar Project Web site (for
password access, contact J.R.D.).
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